CellGenix® rh GM-CSF (Preclinical Grade)
Top Features for Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor:
- Optimal use for expansion of MSCs and maintenance of undifferentiated PSCs
- ADCF Level 2
- High purity to ensure the safety of your process
- Available in two different grades (Preclinical and GMP grade)
Preclinical grade:
- Intended for preclinical ex vivo use
- GMP transferable: Seamless transition from preclinical development to commercial manufacturing
GMP grade:
- Intended for clinical ex vivo use
- Endotoxin Level ≤ 50 EU/mg
- Manufactured in accordance with applicable GMP guidelines
- FDA Drug Master File (DMF) available
- Technical and regulatory support available
- Price (USD):
- $657.00
- Item No.:
- 1412-050
*Custom/bulk order quotes are provided within 72 hours of request.
Letter of Authorization (LOA)
Place a request for a Letter of Authorization (LOA) for our Drug Master File (FDA)
CellGenix® rh Cytokines - Preclinical vs GMP
Both product grades are produced under the same conditions in a GMP facility, ensuring an equal product quality and performance. We offer a more comprehensive QC testing including tighter specifications and documentation for our GMP products: CellGenix® rh Cytokines - Preclinical vs GMP
CellGenix® Preclinical Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) is an animal-derived component-free product. It is produced in a dedicated animal-free GMP facility.
GM-CSF is used in the cell and gene therapy space for its ability to promote dendritic cell (DC) differentiation and function as well as macrophage activity. It is considered a critical factor for the development of DC therapies.
Designed to meet the demands of translational research, CellGenix® preclinical cytokines are ideal to bridge the gap between the lower quality of research grade and the high cost of GMP grade materials.
Please access the Certificate of Analysis on the My Sartorius Portal.
Expiry: 3 years from date of shipping
Datasheet
Safety Datasheet
Applications
-
ApplicationPreclinical ex vivo use
-
Application Area
-
Cell & gene therapy
- Immunology
-
Cell & gene therapy
-
Cell TypeDC
Biological Information
-
Activity≥ 6 x 106 IU/mg
Compliance Information
-
OriginAnimal-Component Free
Features
-
Carrier-Protein FreeYes
Physicochemical Information
-
Endotoxin≤ 1 EU/µg
-
Expression SystemE. coli
Product Information
-
BrandCellGenix®
-
Package TypeVial
-
Size50 µg
Sterility/Purity
-
Delivery ConditionSterile
-
Purity≥ 95%
Weight
-
Molecular Weight (kDa)14.5 kDa